Modulation of the 5-HT₃A receptor current by desacylbaldrinal

Reference

• Ataee R, Ajdary S, Zarrindast M, Rezayat M, Shokrgozar MA, Ataee A. 2010. Y25130 hydrochloride, a selective 5HT3 receptor antagonist has potent antimitogenic and apoptotic effect on HT29 colorectal cancer cell line. Eur J Cancer Prev. 19(2):138–143.
   PubMed Web of Science ®Google Scholar
• Billio A, Morello E, Clarke MJ. 2010. Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. Cochrane Database Syst. Rev. 1. doi:10.1002/14651858.CD006272.pub2.
   Web of Science ®Google Scholar
• Bos R, Hendriks H, Scheffer JJC, Woerdenbag HJ. 1998. Cytotoxic potential of valerian constituents and valerian tinctures. Phytomedicine. 5(3):219–225.
   PubMed Web of Science ®Google Scholar
• Ding P, Yan X, Liu ZH, Du JW, Du YF, Lu YT, Wu D, Xu YH, Zhou HH, Gu Q. 2017. PTS: a pharmaceutical target seeker. Database. 2017:1–7.
   Google Scholar
• Gershon MD. 2004. Review article: serotonin receptors and transporters — roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther. 20(s7):3–14.
   PubMed Web of Science ®Google Scholar
• Goodin S, Cunningham R. 2002. 5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile. Oncologist. 7(5):424–436.
   PubMed Web of Science ®Google Scholar
• Hejazi SH, Ahangari G, Deezagi A. 2016. Alternative viewpoint against breast cancer based on selective serotonin receptors 5HTR3A and 5HTR2A antagonists that can mediate apoptosis in MCF-7 cell line. Curr Drug Discov Technol. 12(4):240–249.
   Google Scholar
• Hassan E, Tayebeh R, Samaneh ET, Zeinalabedin BS, Vahid N, Mehdi Z. 2008. Quantification of valerenic acid and its derivatives in some species of Valeriana L. and Centranthus longiflorus Stev. Asian J Plant Sci. 7(2):195–200.
   Google Scholar
• Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, et al. 2006. American Society of Clinical Oncology guideline for antiemetics in oncology: update. J Clin Oncol. 24(18):2932–2947.
   PubMed Web of Science ®Google Scholar
• Lin S, Chen T, Liu XH, Shen YH, Li HL, Shan L, Liu RH, Xu XK, Zhang WD, Wang H. 2010a. Iridoids and lignans from Valeriana jatamansi. J Nat Prod. 73(4):632–638.
   PubMed Web of Science ®Google Scholar
• Lin S, Shen YH, Zhang ZX, Li HL, Shan L, Liu RH, Xu XK, Zhang WD. 2010. Revision of the structures of 1,5-dihydroxy-3,8-epoxyvalechlorine, volvaltrate B, and valeriotetrate C from Valeriana jatamansi and V. officinalis. J Nat Prod. 73(10):1723–1726.
   PubMed Web of Science ®Google Scholar
• Mathela CS, Chanotiya CS, Sammal SS, Pant AK, Pandey S. 2005. Compositional diversity of terpenoids in the Himalayan Valeriana genera. Chem Biodivers. 2(9):1174–1182.
   PubMed Web of Science ®Google Scholar
• Michael D, Gershon MD. 2005. Nerves, reflexes, and the enteric nervous system. J Clin Gastroenterol. 39(3):S184–S193.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Ishida Y, Kondo M, Shimada S. 2018. Direct modification of the 5-HT3 receptor current by some anticancer drugs. Eur J Pharmacol. 821:21–28.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Ishida Y, Kondo M, Shimada S. 2018. Yokukansan contains compounds that antagonize the 5-HT3 receptor. Phytomedicine. 43:120–125.
   PubMed Web of Science ®Google Scholar
• Olver ME, Stockdale KC, Wormith JS. 2011. A meta-analysis of predictors of offender treatment attrition and its relationship to recidivism. J Consult Clin Psychol. 79(1):6–21.
   PubMed Web of Science ®Google Scholar
• Rudd JA, Jordan CC, Naylor RJ. 1994. Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis. Eur J Pharmacol. 262(1–2):R1–R2.
   PubMed Web of Science ®Google Scholar
• Sun Y, Lan M, Chen X, Dai Y, Zhao X, Wang L, Zhao T, Li Y, Zhu J, Zhang X, et al. 2018. Anti-invasion and anti-metastasis effects of Valjatrate E via reduction of matrix metalloproteinases expression and suppression of MAPK/ERK signaling pathway. Biomed Pharmacother. 104:817–824.
   PubMed Web of Science ®Google Scholar
• Tan YZ, Peng C, Hu CJ, Li HX, Li WB, He JL, Li YZ, Zhang H, Zhang RQ, Wang LX, et al. 2019. Iridoids from Valeriana jatamansi induce autophagy-associated cell death via the PDK1/Akt/mTOR pathway in HCT116 human colorectal carcinoma cells. Bioorg Chem. 87:136–141.
   PubMed Web of Science ®Google Scholar
• Tan YZ, Yong Y, Dong YH, Wang RJ, Li HX, Zhang H, Guo DL, Zhang SJ, Dong XP, Xie XF. 2016. A new secoiridoid glycoside and a new sesquiterpenoid glycoside from Valeriana jatamansi with neuroprotective activity. Phytochem Lett. 17:177–180.
   Web of Science ®Google Scholar
• Tao SY. 2017. Studies of the therapeutic effect and the peripheral mechanism of the iridoid of ZXY from Valeriana jatamansi on the IBS model rats based on the brain-gut interaction [Master 's thesis]. China: Beijing University of Chinese Medicine. Chinese.
   Google Scholar
• Tian SS, Wang ZZ, Wu ZQ, Wei YY, Yang B, Lou SY. 2019. Valtrate from Valeriana jatamansi Jones induces apoptosis and inhibits migration of human breast cancer cells in vitro. Nat Prod Res. 1–4. doi:10.1080/14786419.2018.1548454.
   PubMed Web of Science ®Google Scholar
• Walstab J, Rappold G, Niesler B. 2010. 5-HT(3) receptors: role in disease and target of drugs. Pharmacol Ther. 128(1):146–169.
   PubMed Web of Science ®Google Scholar
• Xu J, Guo P, Guo YQ, Fang LZ, Li YS, Sun ZP, Gui LP. 2011a. Iridoids from the roots of Valeriana jatamansi and their biological activities. Nat Prod Res. 26(21):1996–2001.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhao P, Guo Y, Xie C, Jin DQ, Ma YG, Ma Y, Hou W, Zhang T. 2011b. Iridoids from the roots of Valeriana jatamansi and their neuroprotective effects. Fitoterapia. 82(7):1133–1136.
   PubMed Web of Science ®Google Scholar
• Xu J, Yang B, Guo YQ, Jin DQ, Guo P, Liu C, Hou W, Zhang T, Gui L, Sun Z. 2011c. Neuroprotective bakkenolides from the roots of Valeriana jatamansi. Fitoterapia. 82(6):849–853.
   PubMed Web of Science ®Google Scholar
• Zhang XM, Zhu JL, Sun Y, Dai YL, Chen X, Cao JH, Yang RC, Chen C, Ma CY, Zhang TZ, et al. 2018. Anxiolytic potency of iridoid fraction extracted from Valeriana jatamansi Jones and its mechanism: a preliminary study. Nat Prod Res. 32(17):2071–2075.
   PubMed Web of Science ®Google Scholar